EGF and cancer: In a separate study, Zwaenepoel et al. showed that PR130 prevented epidermal growth factor (EGF) receptor degradation, which resulted in sustained EGF-mediated signaling, driving the cellular proliferation, metastasis, and angiogenesis characteristics of many cancers [48].